Career history of Jürgen Beck
Former positions of Jürgen Beck
Companies | Position | Start | End |
---|---|---|---|
PAION AG | Corporate Officer/Principal | 01/01/2018 | 31/12/2020 |
InterMune International AG | Corporate Officer/Principal | - | - |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Chief Executive Officer | - | - |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Chief Tech/Sci/R&D Officer | 01/12/2015 | - |
EPIGENOMICS AG | Chief Tech/Sci/R&D Officer | 01/01/2010 | - |
Training of Jürgen Beck
Julius-Maximilians-Universität Würzburg | Undergraduate Degree |
Humboldt-Universität zu Berlin | Undergraduate Degree |
University of Hagen | Masters Business Admin |
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistics
International
Germany | 8 |
Belgium | 2 |
Switzerland | 2 |
Operational
Undergraduate Degree | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 5 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
EPIGENOMICS AG | Health Technology |
PAION AG | Health Technology |
Private companies | 3 |
---|---|
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
InterMune International AG |
- Stock Market
- Insiders
- Jürgen Beck
- Experience